ATE419870T1 - Neuer immunogener komplex - Google Patents

Neuer immunogener komplex

Info

Publication number: ATE419870T1
Authority: AT; Austria
Prior art keywords: complex; iscom; antigen; immunogenic complex; integrated
Prior art date: 2000-09-29

Application number

AT01972855T

Other languages

English (en)

Inventor

Nils Lycke

Kristian Dalsgaard

Mowat Allan Mc

Bjoern Loewenadler

Peter Kaastrup

Original Assignee

Isconova Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-29

Filing date

2001-10-01

Publication date

2009-01-15

2001-10-01 Application filed by Isconova Ab filed Critical Isconova Ab

2009-01-15 Application granted granted Critical

2009-01-15 Publication of ATE419870T1 publication Critical patent/ATE419870T1/de

Links

230000002163 immunogen Effects 0.000 title abstract 2
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
239000011159 matrix material Substances 0.000 abstract 2
102000004190 Enzymes Human genes 0.000 abstract 1
108090000790 Enzymes Proteins 0.000 abstract 1
102000043129 MHC class I family Human genes 0.000 abstract 1
108091054437 MHC class I family Proteins 0.000 abstract 1
230000030741 antigen processing and presentation Effects 0.000 abstract 1
229930182470 glycoside Natural products 0.000 abstract 1
150000002338 glycosides Chemical class 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

AT01972855T 2000-09-29 2001-10-01 Neuer immunogener komplex ATE419870T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0003538A SE0003538D0 (sv)	2000-09-29	2000-09-29	New immunogenic complex

Publications (1)

Publication Number	Publication Date
ATE419870T1 true ATE419870T1 (de)	2009-01-15

Family

ID=20281259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01972855T ATE419870T1 (de)	2000-09-29	2001-10-01	Neuer immunogener komplex

Country Status (8)

Country	Link
US (1)	US7452982B2 (de)
EP (1)	EP1320381B1 (de)
AT (1)	ATE419870T1 (de)
AU (2)	AU9249301A (de)
CA (1)	CA2423983C (de)
DE (1)	DE60137347D1 (de)
SE (1)	SE0003538D0 (de)
WO (1)	WO2002026255A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6239116B1 (en) *	1994-07-15	2001-05-29	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US6207646B1 (en) *	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
CN101945666A (zh) *	2007-12-19	2011-01-12	Mivac发展股份公司	治疗自身免疫和过敏性疾病的组合物及方法
US9850296B2 (en)	2010-08-10	2017-12-26	Ecole Polytechnique Federale De Lausanne (Epfl)	Erythrocyte-binding therapeutics
WO2012021512A2 (en)	2010-08-10	2012-02-16	Ecole Polytechnique Federale De Lausanne	Erythrocyte-binding therapeutics
US9517257B2 (en)	2010-08-10	2016-12-13	Ecole Polytechnique Federale De Lausanne (Epfl)	Erythrocyte-binding therapeutics
JP6494527B2 (ja)	2013-02-07	2019-04-03	ザチルドレンズメディカルセンターコーポレーション	肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
US10953101B2 (en)	2014-02-21	2021-03-23	École Polytechnique Fédérale De Lausanne (Epfl)	Glycotargeting therapeutics
US10946079B2 (en)	2014-02-21	2021-03-16	Ecole Polytechnique Federale De Lausanne	Glycotargeting therapeutics
KR102717969B1 (ko)	2014-02-21	2024-10-15	에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘)	글리코타겟팅 치료제
US10046056B2 (en)	2014-02-21	2018-08-14	École Polytechnique Fédérale De Lausanne (Epfl)	Glycotargeting therapeutics
EP3177714A1 (de)	2014-08-08	2017-06-14	Universiteit Utrecht Holding B.V.	Mutantes porzines epizootisches diarrhoevirus zur verwendung als impfstoff
US20180161433A1 (en) *	2017-03-22	2018-06-14	Timothy Andrew Erickson	Size tunable microbial mimetics for immunotherapy of thyroid carcinomas and solid tumors
US11253579B2 (en)	2017-06-16	2022-02-22	The University Of Chicago	Compositions and methods for inducing immune tolerance
EA202092723A1 (ru)	2018-05-09	2021-04-09	Зе Юниверсити Оф Чикаго	Композиции и способы, касающиеся иммунной толерантности
CN110904127B (zh)	2018-09-18	2024-09-20	瓦赫宁恩研究基金会	非洲猪瘟病毒疫苗
JP2023526335A (ja)	2020-05-15	2023-06-21	トランスメッドゴセンバーグアクチボラゲット	免疫賦活活性を有する融合タンパク質
WO2022019769A1 (en)	2020-07-23	2022-01-27	Universiteit Utrecht Holding B.V.	Bordetella outer membrane vesicles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736139A (en)	1989-10-31	1998-04-07	Ochidian Pharmaceuticals, Inc.	Treatment of Clostridium difficile induced disease
EP0648260B1 (de)	1992-06-26	2000-09-27	Kansas State University Research Foundation	Fusobacterium necrophorum leukotoxoid vakzin
US5688772A (en)	1994-08-01	1997-11-18	University Of Saskatchewan	Quinoa saponin compositions and methods of use
US5917026A (en) *	1996-02-05	1999-06-29	Loewenadler; Bjoern	Fusion proteins of immunopotentiating activity
SE9600648D0 (sv) *	1996-02-21	1996-02-21	Bror Morein	Receptorbimdande enhet

2000
- 2000-09-29 SE SE0003538A patent/SE0003538D0/xx unknown
2001
- 2001-10-01 EP EP01972855A patent/EP1320381B1/de not_active Expired - Lifetime
- 2001-10-01 AU AU9249301A patent/AU9249301A/xx active Pending
- 2001-10-01 CA CA2423983A patent/CA2423983C/en not_active Expired - Fee Related
- 2001-10-01 DE DE60137347T patent/DE60137347D1/de not_active Expired - Fee Related
- 2001-10-01 WO PCT/SE2001/002117 patent/WO2002026255A1/en not_active Ceased
- 2001-10-01 AT AT01972855T patent/ATE419870T1/de not_active IP Right Cessation
- 2001-10-01 US US10/381,882 patent/US7452982B2/en not_active Expired - Fee Related
- 2001-10-01 AU AU2001292493A patent/AU2001292493B2/en not_active Ceased

Also Published As

Publication number	Publication date
US20040052815A1 (en)	2004-03-18
AU9249301A (en)	2002-04-08
WO2002026255A1 (en)	2002-04-04
AU2001292493B2 (en)	2006-10-26
CA2423983A1 (en)	2002-04-04
CA2423983C (en)	2012-06-05
SE0003538D0 (sv)	2000-09-29
EP1320381B1 (de)	2009-01-07
EP1320381A1 (de)	2003-06-25
US7452982B2 (en)	2008-11-18
DE60137347D1 (de)	2009-02-26

Legal Events

Date	Code	Title	Description
2009-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60137347D1 (de)	2009-02-26	Neuer immunogener komplex
IS4518A (is)	1999-01-10	Nýtt lyfjaform fyrir bóluefni
CR8231A (es)	2006-07-14	Anticuerpos rg1 y uso de los mismos
BR0208456A (pt)	2004-03-02	Métodos para cultura de circovìrus
MY137202A (en)	2009-01-30	System and method for a unified composition engine in a graphics processing system
TW200515916A (en)	2005-05-16	Chimeric antigens for breaking host tolerance to foreign antigens
PT1053256E (pt)	2011-09-28	Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
TR200101256T2 (tr)	2001-10-22	DNA ile aşılamada geliştirmeler
DK2054431T3 (da)	2012-01-02	Konformere af bakterielle adhæsiner
BRPI0511026A (pt)	2007-11-27	uso de um los neisserial, e, composição
ATE186738T1 (de)	1999-12-15	Kohlenhydratmodifizierte cytostatika
DK1530637T3 (da)	2010-05-31	Carlsberg-subtilisin-proteiner med nedsat immunogenitet
DE60315827D1 (de)	2007-10-04	Verbesserte polysaccharid- und glykokonjugat-vakzine
MY141459A (en)	2010-04-30	Recombinant anti-idiotypic antibodies
ATE245028T1 (de)	2003-08-15	Trimegestone enthaltende pharmazeutische zusammensetzungen
CO5231137A1 (es)	2002-12-27	Clatratos de dehidroepiandrosterona y composiciones farmaceuticas correspondientes
EP1594533A4 (de)	2007-01-17	Antikörper-vakzine-konjugate und ihre verwendungen
WO2001057219A3 (en)	2002-03-07	Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
ATE389397T1 (de)	2008-04-15	Adjuvante zusammensetzungen
AU6078399A (en)	2000-04-17	Ligand presenting assembly (lpa), method of preparation and uses thereof
WO2000044775A3 (en)	2000-11-30	Identification of broadly reactive hla restricted t cell epitopes
BR0311308A (pt)	2005-02-15	Briodina 1 modificada com imunogenicidade reduzida
BR0104357A (pt)	2002-05-21	Uso de receptores de toxina gbs ou fragmentos imunogênicos dela para prevenir uma condição patoangiogênica em um mamìfero
AU2001294565A1 (en)	2002-04-02	In vitro assay for measuring the immunogenicity of a vaccine
Beck et al.	2002	Pyrrolizidine alkaloids from Brickellia grandiflora and Cryptantha jamesii